HGH Releaser and Mitochondrial Enhancer)
StaminoGro is an exciting 5-in-l combination supplement, containing amino acids, anti-oxidants, B-complex vitamins, calcium and vitamin D as well as other essential vitamins and minerals. These ingredients all act in synergy to promote natural growth hormone release and enhance mitochondria! function.
(HGH Releaser and Mitochondrial Enhancer)
•StaminoGro is an exciting 5-in-l combination supplement, containing amino acids, anti-oxidants, B-complex vitamins, calcium and vitamin D as well as other essential vitamins and minerals. These ingredients all act in synergy to promote natural growth hormone release and enhance mitochondria! function.
•As the body gets older, the less natural growth hormone it secretes. The amino acid L-Arginine helps the body to secrete more of its own natural growth hormone leading to anti-aging effects of the body's cells.
Dosage:
For use in sub-fertility -
For optimal effectiveness, take four tablets at night after dinner, two to three hours before sleep or alternatively one hour before exercise, this is to coincide with the body's natural growth hormone release.
It is important to follow a stepped approach when dosing StaminoGro, starting at a low dose initially and gradually build up to the four tablets daily, i.e. for the first week take one tablet daily, second week take two tablets daily, third week take three tablets daily and by the forth week take four tablets daily which is the optimum dose and should be maintained as such.
For use as a general supplement -
Take two tablets at night, after dinner, two to three hours before sleep. This will allow a person to have a much deeper sleep and wake up with more energy.
•StaminoGro may be of benefit to persons suffering from sub-fertility, immune problems, depression, insomnia and fatigue.
•Lactose, sucrose, gluten and tartrazine free.
•Suitable for use by vegetarians.
•SANHA approved.
•Available in containers of 30, 60 or 120 swallow tablets.
•Please visit our website
www.georen.co.za to read up on our clinical tria